ID

34478

Description

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01615406

Link

https://clinicaltrials.gov/show/NCT01615406

Keywords

  1. 1/17/19 1/17/19 -
  2. 5/22/19 5/22/19 -
  3. 5/23/19 5/23/19 - Sarah Riepenhausen
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT01615406

Eligibility Prostate Cancer NCT01615406

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male aged 21 years or older.
Description

ID.1

Data type

boolean

ability to provide signed informed consent and willingness to comply with protocol requirements.
Description

ID.2

Data type

boolean

past biopsy indicating the presence of adenocarcinoma of the prostate gland.
Description

ID.3

Data type

boolean

participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
Description

ID.4

Data type

boolean

have had, or will undergo diagnostic ct or mri imaging prior to surgery.
Description

ID.5

Data type

boolean

participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
Description

ID.6

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
participants for whom participating would significantly delay the scheduled standard of care therapy.
Description

ID.7

Data type

boolean

participants administered a radioisotope within 5 physical half lives prior to study enrollment.
Description

ID.8

Data type

boolean

participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.
Description

ID.9

Data type

boolean

Similar models

Eligibility Prostate Cancer NCT01615406

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male aged 21 years or older.
boolean
ID.2
Item
ability to provide signed informed consent and willingness to comply with protocol requirements.
boolean
ID.3
Item
past biopsy indicating the presence of adenocarcinoma of the prostate gland.
boolean
ID.4
Item
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
boolean
ID.5
Item
have had, or will undergo diagnostic ct or mri imaging prior to surgery.
boolean
ID.6
Item
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
participants for whom participating would significantly delay the scheduled standard of care therapy.
boolean
ID.8
Item
participants administered a radioisotope within 5 physical half lives prior to study enrollment.
boolean
ID.9
Item
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study.
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial